混合心血管扩张性休克:当前见解和未来方向
Jacob C Jentzer1, David D Berg2, Meshe D Chonde3
1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
JACC. Advances
|December 25, 2024
概括
本次审查引入了混合休克的新分类,这是心脏问题和血管扩张并存的危险状况. 早期识别和量身定制的治疗对于改善这些复杂的冲击状态中的患者结果至关重要.
科学领域:
- 关键护理医学 关键护理医学
- 心脏病学 心脏病学
- 血液动力学 血液动力学
背景情况:
- 混合性休克是一种复杂的综合征,涉及同时发生的心肌功能障碍和血管扩张.
- 现有的分类没有充分解决混合冲击的多面性质.
- 糟糕的结果与由于损害的补偿机制造成的混合冲击有关.
研究的目的:
- 为混合冲击提出一种新的分类系统.
- 审查混合休克的病因学,病理生理学和管理策略.
- 突出需要标准化定义和治疗方法的需要.
主要方法:
- 最先进的文献审查.
- 对混合冲击的拟议分类系统的分析.
- 讨论血液动力学概况和管理策略.
主要成果:
- 拟议的分类包括心脏-血管扩张,血管扩张-心脏和初级混合冲击.
- 混合冲击状态通常具有相似的血液动力学特征,尽管病因各异.
- 侵入性血液动力学监测和结合性无otropic / 血管压缩剂支持是管理的关键组成部分.
结论:
- 一个新的分类系统有助于理解和管理混合冲击.
- 及时识别和治疗潜在原因对于改善结果至关重要.
- 需要进一步的研究来建立共识定义,并指导混合冲击中的机械循环支持.
相关概念视频
Blood Pressure Imbalances and Circulatory Shock
719
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
719
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
302
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
302
Heart Failure Drugs: β-Blockers
259
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
259
Heart Failure Drugs: Inotropic Agents
398
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
398
Pathophysiology of Cardiac Performance
471
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
471
Imbalances in Cardiac Output
1.2K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to...
1.2K


